BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 103 filers reported holding BIOXCEL THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $28,000 | -9.7% | 2,183 | -7.3% | 0.00% | – |
| Q2 2022 | $31,000 | -36.7% | 2,354 | 0.0% | 0.00% | – |
| Q1 2022 | $49,000 | +2.1% | 2,354 | 0.0% | 0.00% | – |
| Q4 2021 | $48,000 | -50.5% | 2,354 | -26.4% | 0.00% | – |
| Q3 2021 | $97,000 | +148.7% | 3,197 | +136.1% | 0.00% | – |
| Q2 2021 | $39,000 | -32.8% | 1,354 | 0.0% | 0.00% | – |
| Q1 2021 | $58,000 | +100.0% | 1,354 | +115.6% | 0.00% | – |
| Q4 2020 | $29,000 | +7.4% | 628 | 0.0% | 0.00% | – |
| Q3 2020 | $27,000 | -18.2% | 628 | 0.0% | 0.00% | – |
| Q2 2020 | $33,000 | – | 628 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 430,000 | $19,866,000 | 1.70% |
| APIS CAPITAL ADVISORS, LLC | 20,000 | $924,000 | 0.89% |
| Avidity Partners Management LP | 547,000 | $25,271,000 | 0.82% |
| Knoll Capital Management, LLC | 20,000 | $924,000 | 0.63% |
| Artemis Investment Management LLP | 1,013,448 | $46,839,000 | 0.49% |
| AlphaCentric Advisors LLC | 25,000 | $1,155,000 | 0.48% |
| First Light Asset Management, LLC | 94,202 | $4,352,000 | 0.32% |
| Ikarian Capital, LLC | 150,000 | $6,930,000 | 0.31% |
| Longitude (Cayman) Ltd. | 8,000 | $370,000 | 0.18% |
| AllSquare Wealth Management LLC | 5,490 | $254,000 | 0.17% |